FLUENT Hails U.S. Cannabis Rescheduling as Catalyst for Growth and Market Rationalization

Cansortium ( ($TSE:FNT.U) ) just unveiled an announcement.

FLUENT Corp. has welcomed the U.S. federal decision to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act, calling it a landmark shift that formally acknowledges cannabis’s medical value and moves the industry toward a more rational national regulatory framework. The company expects the change to ease banking access and, crucially, eliminate the impact of Section 280E by allowing normal business tax deductions, freeing up capital for patient care, product development and market expansion. FLUENT also highlighted that recent federal action to curb intoxicating hemp-derived products by late 2026 should materially reduce unlicensed competition and pricing pressure, particularly in key markets such as Florida and potentially Texas, strengthening its competitive position while it continues to advocate for further reforms to reconcile state and federal law and advance criminal justice changes.

More about Cansortium

FLUENT Corp. is a national cannabis consumer packaged goods company and retailer focused on high-quality cannabis products for medical and adult-use communities. The Tampa-based firm oversees cultivation, production, distribution and retail operations across Florida, New York, Pennsylvania and Texas, offering brands such as MOODS, Knack, Wandr, Bag-O and Hyer Kind. FLUENT runs eight cultivation and manufacturing facilities, 37 retail locations and a wholesale division, ENTOURAGE, which services third-party retailers in New York, and its shares trade on the Canadian Securities Exchange and the OTCQB Venture Market.

Learn more about FNT.U stock on TipRanks’ Stock Analysis page.